Biography and Research Information
OverviewAI-generated summary
Francesca Miquel-Verges' research focuses on anticoagulation practices in neonatal respiratory extracorporeal membrane oxygenation (ECMO) therapy. Her work includes a single-center retrospective review examining blood product utilization after invasive procedures in pediatric ECMO, comparing unfractionated heparin and bivalirudin. She has also investigated management strategies for bivalirudin as primary anticoagulation in neonatal respiratory ECMO within the Children’s Hospitals Neonatal Consortium. Miquel-Verges has co-authored publications with collaborators Erin Bennett, Parthak Prodhan, and Rachel Slate, all at the University of Arkansas for Medical Sciences.
Metrics
- Publications: 3
Selected Publications
-
112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin (2024)
Collaboration Network
Top Collaborators
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
- 233: Anticoagulation practices for neonatal respiratory ECMO therapy within the Children’s Hospitals Neonatal Consortium
- 235: Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium
Similar Researchers
Based on overlapping research topics